<qa>  What is the purpose of a multicenter, prospective, open-label, single-Multicenter, Prospective, Open-Label, Single-Arm Trial to Evaluate the Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen FIB Grifols in Patients with Congenital Afibrinogenaemia 